Furthermore, in a previous study of patients with RA and DM, abatacept initiators had a lower risk of myocardial infarction and coronary revascularization compared with TNF inhibitor (TNFi) initiators [6]. The gene discussed is TNF; the disease is rheumatoid arthritis.